Related Experiment Video
Updated: Jul 18, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
A measure of the performance of biomarkers for disease
1CSIRO Mathematical and Information Sciences, Glen Osmond, Australia.
Abstract:
The statistical properties required for effective biomarkers for disease are examined. It is shown that an "effectiveness parameter" D can be calculated that summarises the performance of a given biomarker and can distinguish between effective and ineffective biomarkers. D can be readily calculated from published summaries of biomarker levels and provides a simpler alternative to the commonly used "Area under the Curve" statistic. The impact of within-individual and between-individual variation in biomarker levels is also evaluated. An approach to the choice of sample size for experiments to estimate D is described.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Receiver Operating Characteristic Plot
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...

